How does it work?

Inflammatory bowel disease (IBD) is a chronic, progressive, and disabling inflammatory disease of the gastrointestinal tract that encompasses Ulcerative Colitis and Crohn’s Disease. Although there is no cure for IBD, medication can suppress symptoms and inflammation, improving the patient’s quality of life and preventing complications.

However, tight control of IBD disease activity can be time-consuming and expensive for both patients and healthcare professionals. To address this, eHealth technologies have been developed, and studies have shown that telemonitoring IBD patients can significantly reduce hospital visits and admissions, and alleviate the burden on healthcare resources.

Luscii's IBD telemonitoring program is a tailor-made solution that educates and empowers patients. The Luscii app includes the MIAH questionnaire and a home faecal calprotectin test that reports the patient's disease status at a specific time. This information enables healthcare professionals to provide customized care and virtual follow-up, improving disease control and reducing the need for hospital visits.